UTHR - United Therapeutics Corporation

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts10101013
Avg. Estimate3.873.5710.610.85
Low Estimate2.962.768.527.61
High Estimate4.255.1415.2413.16
Year Ago EPS3.52.4915.3110.6
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts11111313
Avg. Estimate426.43M396.26M1.63B1.31B
Low Estimate384.85M359.2M1.53B992.68M
High Estimate443.82M459.2M1.72B1.55B
Year Ago Sales408.2M409M1.6B1.63B
Sales Growth (year/est)4.50%-3.10%1.80%-19.70%
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.3.343.613.313.61
EPS Actual3.52.493.89-1.25
Difference0.16-1.120.58-4.86
Surprise %4.80%-31.00%17.50%-134.60%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate3.873.5710.610.85
7 Days Ago3.873.5710.610.85
30 Days Ago3.873.5710.0910.66
60 Days Ago3.873.5710.0910.66
90 Days Ago3.693.4714.410.96
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 Days1111
Up Last 30 Days1123
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesUTHRIndustrySectorS&P 500
Current Qtr.10.60%N/AN/A0.17
Next Qtr.43.40%N/AN/A0.27
Current Year-30.80%N/AN/A0.07
Next Year2.40%N/AN/A0.12
Next 5 Years (per annum)-29.31%N/AN/A0.10
Past 5 Years (per annum)30.41%N/AN/AN/A